蒙药治疗BPH术后膀胱过度活动症临床观察

Treatment of Overactive Bladder with Mongolian Medicine after Benign Prostatic Hyperplasia Surgery

目的:观察蒙药治疗良性前列腺增生(BPH)术后膀胱过度活动症的临床疗效.方法:将41例患者随机分为治疗组、对照组及空白组,治疗组术后6小时起给予蒙药协日嘎-4汤和苏格木勒-10,对照组术后6小时起给予托特罗定缓释片,空白组给予对症治疗,对比比较VAS疼痛评分及OABSS评分.结果:治疗组、对照组术后24、48小时VAS评分及OABSS评分与空白组比较有统计学差异(P<0.05).结论:蒙药治疗TURP术后OAB疗效确切.

Objective： Observe the clinical effect of overactive bladder（OAB）treatment by Mongolian medicine after benign prostatic hyperplasia（BPH）surgery. Methods：Forty-one patients were randomly divided into a treatment group, a control group and a blank group. Six hours after surgery, the treatment group was given Xiriga-4 and Sugemule-10 Mongolian drugs, the control group was given Tolterodine Tartrate Sustained Release Tablets and the blank group was given symptomatic treatment. The VAS pain score and the OABSS scores were observed and compared. Results：Twenty-four and 48 hours after surgery, the VAS pain and OABSS scores in the treatment and control groups were significantly better than those of the blank group（P0.05）. Conclusion：Mongolian medicine has a definite effect in the treatment of OAB after transurethral resection of the prostate（TURP）surgery.